Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

NCT02711228 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT02711228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02711228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
Lead sponsor
CSL Behring
Phase
Phase 4
Overall status
Completed
Start date
March 15, 2016
Completion date
January 30, 2018
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary immune deficiency, secondary immune deficiency